Drug intelligence / Profile preview

policosanol

Development stage
Phase 4
Modality
Classical Binding Small Molecules → Small Molecules, Covalent Small Molecules → Small Molecules, Nucleic Acid-Directed Small Molecules → Small Molecules
Administration
Oral
01

Overview

Policosanol is a natural mixture of long-chain aliphatic alcohols primarily derived from sugarcane wax but can also be sourced from beeswax and other plant waxes. It is most commonly promoted as a dietary supplement for managing high cholesterol and cardiovascular health. The main component is octacosanol. Mechanistically, policosanol appears to inhibit cholesterol biosynthesis at the early steps of the pathway and enhances low-density lipoprotein (LDL) processing by increasing LDL binding and degradation in cells. It also decreases platelet aggregation by reducing thromboxane B2 synthesis without affecting prostacyclin levels. While some studies—mainly from Cuba—have reported significant lipid-lowering effects comparable to statins and benefits for intermittent claudication (improved walking distance), independent trials have not consistently confirmed these findings. Policosanol has been approved as a treatment for high cholesterol in several countries (mostly Latin America), but evidence supporting its efficacy remains inconclusive[1][3][5][6][8].

Brand names
Policosanol MAXPMAX
Other names
octacosanol32-Cdotriacontanolheptacosanolhexacosanolnonacosanoltetracosanoltétracosanoltetratriacontanoltétratriacontanoltriacontanol
02

Targets

HMGCR (3-hydroxy-3-methylglutaryl-coenzyme A reductase)LDLR (Low-density lipoprotein receptor)TBXAS1 (Thromboxane A2 synthase)

Beyond the preview

Go deeper on policosanol.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on policosanol.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call